We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

12:HKEXBYD Company Limited Analysis

Data as of 2026-07-16 - not real-time

HK$76.10

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

AIA’s price is trading above its short‑term moving average while sitting below the medium‑term average, suggesting mixed momentum. The MACD histogram is positive and the RSI sits in a neutral zone, offering a hint of short‑term bullishness despite a broader bearish trend and falling volume. Valuation metrics show the stock priced below comparable peers on a price‑to‑earnings basis and delivering a dividend yield that exceeds two percent with a comfortable payout ratio, indicating dividend sustainability. Analyst sentiment is strongly positive, with a consensus of strong buy and target prices well above the current level, implying substantial upside. The balance sheet is solid, featuring ample cash relative to debt and robust free cash flow, which supports both growth initiatives and dividend payments. Geographic diversification across many Asian markets adds resilience, though exposure to regulatory environments in those jurisdictions remains a consideration.
Given the blend of technical signals, attractive valuation, and strong fundamentals, the stock presents a compelling case for investors seeking both growth and income. The low beta points to limited market‑wide volatility, while the high recent volatility reflects short‑term price swings rather than fundamental weakness. Overall, AIA appears positioned for a continued rally, especially if the broader market sentiment remains in the “extreme greed” phase.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Positive MACD histogram indicating short‑term bullish momentum
  • Price above the short‑term moving average but below the medium‑term average
  • Decreasing volume suggesting weakening buying pressure

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Valuation below industry PE average and significant upside to analyst targets
  • Strong earnings growth and solid cash generation
  • Attractive dividend yield with a sustainable payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Robust balance sheet with cash comfortably covering debt
  • Diversified geographic footprint across Asia reducing concentration risk
  • Low beta and consistent dividend policy supporting long‑term stability

Key Metrics & Analysis

Financial Health

Revenue Growth6.00%
Profit Margin23.78%
P/E Ratio16.4
ROE14.85%
ROA1.87%
Debt/Equity47.20
P/B Ratio2.3
Op. Cash FlowHK$7.0B
Free Cash FlowHK$5.1B
Industry P/E17.9

Technical Analysis

TrendBearish
RSI54.4
SupportHK$69.35
ResistanceHK$77.30
MA 20HK$73.32
MA 50HK$78.46
MA 200HK$80.56
MACDBullish
VolumeDecreasing
Fear & Greed Index92.45

Valuation

Fair ValueHK$7.12
Target PriceHK$104.10
Upside/Downside36.79%
GradeUndervalued
TypeBlend
Dividend Yield2.53%

Risk Assessment

Beta0.67
Volatility36.42%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.